BC Innovations | Feb 10, 2011
Distillery Therapeutics

Indication: Cardiovascular disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Coronary artery disease (CAD); myocardial infarction (MI) ABO blood group (ABO); ADAM metallopeptidase with thrombospondin type 1 motif 7 (ADAMTS7) Genomewide association studies identified...
Items per page:
1 - 1 of 1